Suggestions
Steve Hahn
Experienced CEO and Medical Executive
Steve Hahn is a prominent healthcare executive and former government official with extensive experience in oncology and medical research. He currently serves as the CEO of Harbinger Health and CEO-Partner at Flagship Pioneering.34
Professional Background
Dr. Hahn has had a distinguished career spanning various leadership roles:
- Current Positions: CEO of Harbinger Health and CEO-Partner at Flagship Pioneering since December 2021.3
- Government Service: Served as the 24th Commissioner of the U.S. Food and Drug Administration (FDA) from December 2019 to January 2021.12
- Academic Medicine: Prior to his FDA role, he held several high-ranking positions at MD Anderson Cancer Center, including Chief Medical Executive and Deputy President/Chief Operating Officer.12
- Research and Clinical Practice: Focused on radiation oncology, with leadership roles at the University of Pennsylvania's Perelman School of Medicine.12
Education and Training
Dr. Hahn's educational background includes:
- M.D. from Temple University School of Medicine.13
- B.A. in Biology from Rice University.13
- Residency in internal medicine at the University of California San Francisco.12
- Fellowship and residency at the National Cancer Institute in Bethesda, Maryland.12
Current Focus
At Harbinger Health, Dr. Hahn is working on pioneering the detection of early cancer through blood-based tests.4 The company aims to develop affordable and accessible early-stage cancer screening methods.5
Research and Publications
Throughout his career, Dr. Hahn has made significant contributions to medical research:
- Authored over 220 peer-reviewed original research articles.12
- Focused on tumor microenvironment, signal transduction pathways, and proton therapy.12
Dr. Hahn's diverse experience in healthcare leadership, oncology, and regulatory affairs has positioned him as a key figure in the development of innovative health technologies and cancer detection methods.
Highlights
Talking early cancer detection at #HLTH2023 with Chevon Rariy, MD, Anabella Aspiras, AmirAli Talasaz, and Othman Laraki. Each of us are tackling this from different sides with the same goal in mind: saving lives through better access to screening. Looking forward to coming together again and again as we collectively work against this goal.
I’m thrilled to welcome Dymeka Harrison, Matt Sargent and Gisela A. Paulsen, MPharm to the Harbinger Health team. The collective expertise of this group is second to none and imperative as we continue to grow. https://lnkd.in/gWbKFT3r
